Overview
JIUYUAN GENE (2566)
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of...
- Open
- 4.275
- High
- 4.275
- Low
- 4.250
- Prev. Close
- 4.260
- Volume
- 5.20K
- Turnover
- 22.14K
- Avg Price
- 4.258
- Bid/Ask Ratio
- 50.00%
- Amplitude
- 0.59%
- 52wk High
- 10.774
- Volume Ratio
- 0.32
- Turnover Ratio
- 0.00%
- 52wk Low
- 4.200
- HK Mkt Cap
- 1.01B
- Market CapHKD
- 1.01B
- P/ETTM
- 6.27
- P/EDynamic
- 4.79
- P/EStatic
- --
- EPSTTM
- 0.679
- EPSDynamic
- 0.889
- EPSStatic
- --
- BVPS
- 8.21
- P/B
- 0.52
- HK Shares
- 236.52M
- Dividend YieldTTM
- 1.57%
- DividendTTM
- 0.067
- Shares
- 236.52M
- Min lot size
- 200
- Currency
- HKD
Daily Events
- Jul, 2
Hangzhou Jiuyuan Genetic Biopharmaceutical staged a sharp rally in the afternoon session, closing at HKD 6.62 for a 12.20% gain vs. the prior close of HKD 5.90. The stock formed a deep intraday reversal, hitting a low of HKD 5.84 before surging to an intraday high of HKD 6.95, yielding an 18.81% daily range. The company has repeatedly filed HKEX next-day disclosure returns on share repurchases (e.g., average prices from HKD 5.72 to HKD 5.83) and cancellations, signaling strong management confidence amid a previously announced up-to-CNY 100 million buyback plan. On fundamentals, Q4 2025 net profit jumped 51.62% YoY to HKD 26.8 million, while operating profit surged 60.98% YoY, building on the recovery trend seen in Q3. The stock trades at a PE of 10.4x and a PB of 0.87x. However, the price still sits 59.36% below its 52-week high (HKD 16.29) and 13.01% lower YTD, suggesting the rally owes more to buyback momentum than a re-rating.
News
Market Movers · JIUYUAN GENE hits a new 52-week low, currently trading at $4.20, down approximately 3%
Market Movers · Jiuyuan Gene slips to record low
Market Movers · JIUYUAN GENE hits a new 52-week low, currently trading at $4.45, down approximately 3%
PUBT · China's CDE Accepts Hangzhou Jiuyuan's JY54-2 Clinical Trial Application
Market Movers · Jiuyuan Gene drops 7% in Hong Kong trading
PUBT · Hangzhou Jiuyuan Gene Discloses Share Buyback in HKEX Next-Day Return
